This measure summary has been replaced by an updated version. Please update your bookmarks.
View the updated summary: Atrial fibrillation (AF) and atrial flutter: percentage of patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter whose assessment of the specified thromboembolism risk factors indicate one or more high-risk factors or more than one moderate risk factor, as determined by CHADS<sub>2 </sub>risk stratification, who are prescribed warfarin OR another oral anticoagulant drug that is FDA approved for the prevention of thromboembolism. NQMC:008971
View all updated summaries in the Measure Archive.